Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;16(3):149-155.
doi: 10.12788/jhm.3529.

Antibiotic Regimens and Associated Outcomes in Children Hospitalized With Staphylococcal Scalded Skin Syndrome

Affiliations

Antibiotic Regimens and Associated Outcomes in Children Hospitalized With Staphylococcal Scalded Skin Syndrome

Hannah C Neubauer et al. J Hosp Med. 2021 Mar.

Abstract

Background: Controversy exists regarding the optimal antibiotic regimen for use in hospitalized children with staphylococcal scalded skin syndrome (SSSS). Various regimens may confer toxin suppression and/or additional coverage for methicillin-susceptible Staphylococcus aureus (MSSA) or methicillin-resistant S aureus (MRSA).

Objectives: To describe antibiotic regimens in hospitalized children with SSSS and examine the association between antistaphylococcal antibiotic regimens and patient outcomes.

Design/methods: Retrospective cohort study of children hospitalized with SSSS using the Pediatric Health Information System database (2011-2016). Children who received clindamycin monotherapy, clindamycin plus MSSA coverage (eg, nafcillin), or clindamycin plus MRSA coverage (eg, vancomycin) were included. The primary outcome was hospital length of stay (LOS); secondary outcomes were treatment failure and cost. Generalized linear mixed-effects models were used to compare outcomes among antibiotic groups.

Results: Of 1,259 children included, 828 children received the most common antistaphylococcal antibiotic regimens: clindamycin monotherapy (47%), clindamycin plus MSSA coverage (33%), and clindamycin plus MRSA coverage (20%). Children receiving clindamycin plus MRSA coverage had higher illness severity (44%) compared with clindamycin monotherapy (28%) and clindamycin plus MSSA (32%) (P =.001). In adjusted analyses, LOS and treatment failure did not differ among the 3 regimens (P =.42 and P =.26, respectively). Cost was significantly lower for children receiving clindamycin monotherapy and highest in those receiving clindamycin plus MRSA coverage (mean, $4,839 vs $5,348, respectively; P <.001).

Conclusions: In children with SSSS, the addition of MSSA or MRSA coverage to clindamycin monotherapy was associated with increased cost and no incremental difference in clinical outcomes.

PubMed Disclaimer

Figures

FIG
FIG
Flow Chart of Study Population Abbreviations: PHIS, Pediatric Health Information System; SSSS, staphylococcal scalded skin syndrome.

References

    1. Staiman A, Hsu DY, Silverberg JI. Epidemiology of staphylococcal scalded skin syndrome in United States children. Br J Dermatol. 2018;178(3):704–708. doi: 10.1111/bjd.16097. doi: 10.1111/bjd.16097. - DOI - DOI - PubMed
    1. Hulten KG, Kok M, King KE, Lamberth LB, Kaplan SL. Increasing numbers of staphylococcal scalded skin syndrome cases caused by ST121 in Houston, TX. Pediatr Infect Dis J. 2020;39(1):30–34. doi: 10.1097/INF.0000000000002499. doi: 10.1097/INF.0000000000002499. - DOI - DOI - PubMed
    1. Arnold JD, Hoek SN, Kirkorian AY. Epidemiology of staphylococcal scalded skin syndrome in the United States: A cross-sectional study, 2010-2014. J Am Acad Dermatol. 2018;78(2):404–406. doi: 10.1016/j.jaad.2017.09.023. doi: 10.1016/j.jaad.2017.09.023. - DOI - DOI - PubMed
    1. Hayward A, Knott F, Petersen I, et al. Increasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England. Emerg Infect Dis. 2008;14(5):720–726. doi: 10.3201/eid1405.070153. doi: 10.3201/eid1405.070153. - DOI - DOI - PMC - PubMed
    1. Berk DR, Bayliss SJ. MRSA, staphylococcal scalded skin syndrome, and other cutaneous bacterial emergencies. Pediatr Ann. 2010;39(10):627–633. doi: 10.3928/00904481-20100922-02. doi: 10.3928/00904481-20100922-02. - DOI - DOI - PubMed

Publication types

MeSH terms

Substances